890 results on '"Egan, Josephine M"'
Search Results
102. Glucose Tolerance, Glucose Utilization and Insulin Secretion in Ageing
103. Glucagon-like peptide-1 (7-37) augments insulin-mediated glucose uptake in elderly patients with diabetes
104. To Be or Not To Be—Obese
105. Cross-Sectional Evidence of a Signaling Pathway from Bone Homeostasis to Glucose Metabolism
106. Cannabinoids Inhibit Insulin Receptor Signaling in Pancreatic β-Cells
107. 2044-P: Loss of CB1R Protects against Streptozotocin-Induced ß-Cell Dysfunction in Mice
108. 1719-P: Novel Mass Spectrometry–Based Selected Reaction Monitoring Proteomics for Analysis of Low Abundant Insulin Levels in Cerebrospinal Fluid
109. The Relationship of Lean Body Mass With Aging to the Development of Diabetes
110. Medium Chain Triglycerides induce mild ketosis and may improve cognition in Alzheimer’s disease. A systematic review and meta-analysis of human studies
111. Release of insulin produced by the choroid plexis is regulated by serotonergic signaling
112. Adipocytokines and the metabolic syndrome among older persons with and without obesity: the InCHIANTI study
113. A Pilot Study of Exenatide Actions in Alzheimer’s Disease
114. Vasoactive Intestinal Peptide–Null Mice Demonstrate Enhanced Sweet Taste Preference, Dysglycemia, and Reduced Taste Bud Leptin Receptor Expression
115. Incretins in obesity and diabetes
116. Exogenous Glucose–Dependent Insulinotropic Polypeptide Worsens Post prandial Hyperglycemia in T ype 2 Diabetes
117. Exendin-4 Improves Glycemic Control, Ameliorates Brain and Pancreatic Pathologies, and Extends Survival in a Mouse Model of Huntingtonʼs Disease
118. Biology and therapeutic potential of GLP-1 in the treatment of diabetes
119. Incretin-Based Therapies in Type 2 Diabetes Mellitus
120. Modulation of taste sensitivity by GLP-1 signaling
121. Exogenous glucose--dependent insulinotropic polypeptide worsens postprandial hyperglycemia in type 2 diabetes
122. Glucose and Insulin Measurements from the Oral Glucose Tolerance Test and Mortality Prediction
123. Mechanisms of action of glucagon-like peptide 1 in the pancreas
124. Notch Mediates Insulinotropic Signaling in β-Cells: 1557-P
125. The Insulinomimetic Actions of GLP-1 (9–36) Amide, Cleavage Product of GLP-1 (7–36) Amide: 363-OR
126. The effects of GLP-1 on insulin release in young and old rats in the fasting state and during an intravenous glucose tolerance test
127. Peptide YY Is Secreted after Oral Glucose Administration in a Gender-Specific Manner
128. Molecular investigation of age-related changes in mouse endocrine pancreas
129. Differential expression of reg-I and reg-II genes during aging in the normal mouse
130. Elevated Plasma Glucose-Dependent Insulinotropic Polypeptide Associates With Hyperinsulinemia in Impaired Glucose Tolerance
131. Age-dependent reduction in insulin secretion and insulin mRNA in isolated islets from rats
132. Arginine enhances glycogen synthesis in response to insulin in 3T3-L1 adipocytes
133. Glucagon-like peptide 1 modulates calcium responses to glutamate and membrane depolarization in hippocampal neurons
134. Effects of 3 Months of Continuous Subcutaneous Administration of Glucagon-Like Peptide 1 in Elderly Patients With Type 2 Diabetes
135. Plasma Adiponectin and Leptin Levels, Body Composition, and Glucose Utilization in Adult Women With Wide Ranges of Age and Obesity
136. Effect of Glucagon-Like Peptide 1 (7-36 Amide) on Insulin-Mediated Glucose Uptake in Patients With Type 1 Diabetes
137. Chapter 79 - Resveratrol in Aging and Age-Related Diseases
138. Glucagon-Like Peptide-1 Augments Insulin-Mediated Glucose Uptake in the Obese State
139. Effect of glucagon-like peptide 1 (7.36 amide) on insulin-mediated glucose uptake in patients with type 1 diabetes. (Original Article: Pathophysiology/Complications)
140. The Insulinotropic Effect of Acute Exendin-4 Administered to Humans: Comparison of Nondiabetic State to Type 2 Diabetes
141. Effect of Glucagon-Like Peptide 1 on Non-Insulin-Mediated Glucose Uptake in the Elderly Patient With Diabetes
142. Insertion of an N-Terminal 6-Aminohexanoic Acid after the 7 Amino Acid Position of Glucagon-Like Peptide-1 Produces a Long-Acting Hypoglycemic Agent
143. Glucagon-Like Peptide-1 (7-37) Augments Insulin Release in Elderly Patients With Diabetes
144. Glucagon-Like Peptide-1 Causes Pancreatic Duodenal Homeobox-1 Protein Translocation from the Cytoplasm to the Nucleus of Pancreatic β-Cells by a Cyclic Adenosine Monophosphate/Protein Kinase A-Dependent Mechanism
145. Glucagon-Like Peptide-1 Induces Cell Proliferation and Pancreatic-Duodenum Homeobox-1 Expression and Increases Endocrine Cell Mass in the Pancreas of Old, Glucose-Intolerant Rats
146. Impaired Insulin Secretion and Increased Insulin Sensitivity in Familial Maturity-Onset Diabetes of the Young 4 (Insulin Promoter Factor 1 Gene)
147. Exendin-4 Decelerates Food Intake, Weight Gain, and Fat Deposition in Zucker Rats
148. Insulinotropic Glucagon-Like Peptide 1 Agonists Stimulate Expression of Homeodomain Protein IDX-1 and Increase Islet Size in Mouse Pancreas
149. Erratum to: Denatonium induces secretion of glucagon-like peptide-1 through activation of bitter taste receptor pathways
150. Glucagon-Like Peptide 1 and Exendin-4 Convert Pancreatic AR42J Cells Into Glucagon- and Insulin-Producing Cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.